Immunogenicity of the seven valent pneumococcal conjugate vaccine in patients with ataxia-telangiectasia

Pediatric Infectious Disease Journal

Volumn 23, Issue 3, 2004, Pages 269-270

  Schubert, Ralf ^a   Reichenbach, Janine ^a   Rose, Markus ^a   Zielen, Stefan ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Ataxia telangiectasia; Immunodeficiency; Pneumococcal disease; Seven valent pneumococcal conjugate vaccine

Indexed keywords

BACTERIUM ANTIBODY; PNEUMOCOCCUS VACCINE;

ANTIBODY TITER; ARTICLE; ATAXIA TELANGIECTASIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HIGH RISK PATIENT; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION;

ADOLESCENT; ADULT; ATAXIA TELANGIECTASIA; BACTERIAL VACCINES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; VACCINES, CONJUGATE;

EID: 1542723745     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000115737.35353.55     Document Type: Article

References (6)

1. Oxelius VA, Berkel A, Hanson LA. IgG2 deficiency in ataxia telangiectasia. N Engl J Med 1982;306:5157.
2. + T cell subsets in ataxia telangiectasia. Clin Exp Immunol 2002;129:125-32.
3. Black S, Shinefield H, Fireman B, et al. Efficacy, safety, and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000;19:187-95.
4. Pelton SI, Klein JO. The future of pneumococcal conjugate vaccines for prevention of pneumococcal diseases in infants and children. Pediatrics 2002;110:805-14.
5. Zielen S, Broker M, Strnad, et al. Simple determination of polysaccharide specific antibodies by means of chemically modified ELISA plates. J Immunol Methods 1996;193:1-7.
6. Sanal O, Ersoy F, Yel L, et al. Impaired IgG antibody production to pneumococcal polysaccharides in patients with ataxia-telangiectasia. J Clin Immunol 1999;19:326-33. Brief Report